Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

DSpace Repository

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

Author: Auel, Britta; Goldschmidt, Hartmut; Geer, Thomas; Moehler, Thomas M.; Platzbecker, Uwe; Naumann, Ralph; Blau, Igor; Haenel, Mathias; Knauf, Wolfgang; Nueckel, Holger; Salwender, Hans-Juergen; Scheid, Christof; Weisel, Katja; Gorschlueter, Marcus; Glasmacher, Axel; Schmidt-Wolf, Ingo G. H.
Tübinger Autor(en):
Weisel, Katja
Published in: Indian Journal of Hematology and Blood Transfusion (2012), Bd. 28, H. 2, S. 67-76
Verlagsangabe: Springer India
Language: English
Full text: http://dx.doi.org/10.1007/s12288-011-0103-1
ISSN: 0971-4502
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)